Can Fite Biofarma Ltd (CANF)
2.09
0.00 (0.00%)
USD |
NYAM |
May 02, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
Can Fite Biofarma Enterprise Value: 1.508M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 1.508M |
April 30, 2024 | 1.408M |
April 29, 2024 | 0.9091M |
April 26, 2024 | 0.959M |
April 25, 2024 | 0.6596M |
April 24, 2024 | 0.7594M |
April 23, 2024 | 0.9091M |
April 22, 2024 | 0.959M |
April 19, 2024 | 0.959M |
April 18, 2024 | 0.9091M |
April 17, 2024 | 0.8592M |
April 16, 2024 | 1.458M |
April 15, 2024 | 1.408M |
April 12, 2024 | 1.558M |
April 11, 2024 | 2.456M |
April 10, 2024 | 2.805M |
April 09, 2024 | 2.356M |
April 08, 2024 | 3.055M |
April 05, 2024 | 2.805M |
April 04, 2024 | 2.706M |
April 03, 2024 | 2.506M |
April 02, 2024 | 2.281M |
April 01, 2024 | 2.606M |
March 28, 2024 | 2.157M |
March 27, 2024 | 1.322M |
Date | Value |
---|---|
March 26, 2024 | 0.9595M |
March 25, 2024 | 1.005M |
March 22, 2024 | 1.186M |
March 21, 2024 | 1.005M |
March 20, 2024 | 1.186M |
March 19, 2024 | 0.9595M |
March 18, 2024 | 1.005M |
March 15, 2024 | 0.6875M |
March 14, 2024 | 0.7782M |
March 13, 2024 | 1.232M |
March 12, 2024 | 0.7782M |
March 11, 2024 | 1.277M |
March 08, 2024 | 1.096M |
March 07, 2024 | 0.8688M |
March 06, 2024 | 0.7329M |
March 05, 2024 | 0.5969M |
March 04, 2024 | 0.7782M |
March 01, 2024 | 0.7329M |
February 29, 2024 | 0.7782M |
February 28, 2024 | 0.5067M |
February 27, 2024 | 0.5969M |
February 26, 2024 | 0.5969M |
February 23, 2024 | 0.4156M |
February 22, 2024 | 0.5969M |
February 21, 2024 | 0.3702M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.721M
Minimum
Apr 12 2023
41.86M
Maximum
Mar 16 2021
10.91M
Average
9.533M
Median
Enterprise Value Benchmarks
Compugen Ltd | 127.12M |
Pluri Inc | 24.07M |
BioLine Rx Ltd | 20.50M |
XTL Biopharmaceuticals Ltd | 12.02M |
BiomX Inc | 20.83M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.652M |
Revenue (Quarterly) | 0.155M |
Total Expenses (Quarterly) | 1.989M |
EPS Diluted (Quarterly) | -1.517 |
Profit Margin (Quarterly) | -1.07K% |
Earnings Yield | -143.5% |
Normalized Earnings Yield | -143.54 |